NO20016224L - Farmasöytisk blanding inneholdende sibutramin og orlistat - Google Patents
Farmasöytisk blanding inneholdende sibutramin og orlistatInfo
- Publication number
- NO20016224L NO20016224L NO20016224A NO20016224A NO20016224L NO 20016224 L NO20016224 L NO 20016224L NO 20016224 A NO20016224 A NO 20016224A NO 20016224 A NO20016224 A NO 20016224A NO 20016224 L NO20016224 L NO 20016224L
- Authority
- NO
- Norway
- Prior art keywords
- orlistat
- pharmaceutical composition
- composition containing
- containing sibutramine
- sibutramine
- Prior art date
Links
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 title 1
- 229960001243 orlistat Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- UNAANXDKBXWMLN-UHFFFAOYSA-N sibutramine Chemical compound C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UNAANXDKBXWMLN-UHFFFAOYSA-N 0.000 title 1
- 229960004425 sibutramine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9914744.9A GB9914744D0 (en) | 1999-06-24 | 1999-06-24 | Therapeutic agents |
| PCT/EP2000/005542 WO2001000205A1 (en) | 1999-06-24 | 2000-06-16 | Pharmaceutical composition containing sibutramine and orlistat |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20016224D0 NO20016224D0 (no) | 2001-12-19 |
| NO20016224L true NO20016224L (no) | 2002-02-12 |
Family
ID=10855955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20016224A NO20016224L (no) | 1999-06-24 | 2001-12-19 | Farmasöytisk blanding inneholdende sibutramin og orlistat |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1187606A1 (cs) |
| JP (1) | JP2003503349A (cs) |
| KR (1) | KR20020015357A (cs) |
| CN (1) | CN1358092A (cs) |
| AU (1) | AU5533200A (cs) |
| BG (1) | BG106180A (cs) |
| BR (1) | BR0011880A (cs) |
| CA (1) | CA2375972A1 (cs) |
| CZ (1) | CZ20014613A3 (cs) |
| GB (1) | GB9914744D0 (cs) |
| HK (1) | HK1049278A1 (cs) |
| HU (1) | HUP0201878A3 (cs) |
| IL (1) | IL147079A0 (cs) |
| MX (1) | MXPA01012936A (cs) |
| NO (1) | NO20016224L (cs) |
| PL (1) | PL352402A1 (cs) |
| RU (1) | RU2229289C2 (cs) |
| SK (1) | SK18242001A3 (cs) |
| TR (1) | TR200103699T2 (cs) |
| WO (1) | WO2001000205A1 (cs) |
| ZA (1) | ZA200109989B (cs) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6696495B2 (en) * | 1998-12-02 | 2004-02-24 | Snowden Pharmaceuticals, Llc | Treatment of disorders secondary to organic impairments |
| US20040214804A1 (en) * | 2003-04-25 | 2004-10-28 | Pharmacia Corporation | Combination of an aldosterone receptor antagonist and an anti-obesity agent |
| JP2008517976A (ja) | 2004-10-25 | 2008-05-29 | ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cb1カンナビノイド受容体拮抗薬及びカリウムチャンネルオープナーから成る、真性糖尿病1型、肥満及び関連症状の治療用の医薬組成物 |
| CA2663254C (en) | 2006-09-15 | 2016-04-19 | Reviva Pharmaceuticals, Inc. | Synthesis, methods of using, and compositions of cycloalkylmethylamines |
| KR20080046601A (ko) * | 2006-11-22 | 2008-05-27 | 에스케이케미칼주식회사 | 보관안정성이 우수한 시부트라민 함유 포접복합체 |
| CN101890017A (zh) * | 2009-05-22 | 2010-11-24 | 北京奥萨医药研究中心有限公司 | 含有西布曲明和他汀类降脂药物的药物组合物及其用途 |
| WO2012003501A2 (en) | 2010-07-02 | 2012-01-05 | Reviva Pharmaceuticals, Inc. | Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives |
| MX336980B (es) * | 2010-12-21 | 2016-02-09 | Senosiain S A De C V Lab | Combinacion y composicion para el tratamiento de obesidad. |
| US9238625B2 (en) | 2011-12-30 | 2016-01-19 | Reviva Pharmaceuticals, Inc. | Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW381025B (en) * | 1993-08-05 | 2000-02-01 | Hoffmann La Roche | Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor |
| US5459164A (en) * | 1994-02-03 | 1995-10-17 | Boots Pharmaceuticals, Inc. | Medical treatment |
| RU2119156C1 (ru) * | 1996-06-05 | 1998-09-20 | Открытое акционерное общество "Киришинефтеоргсинтез" | Устройство диагностики состояния нефтей по их активной электропроводности |
| GB9619757D0 (en) * | 1996-09-21 | 1996-11-06 | Knoll Ag | Chemical process |
| GB9727131D0 (en) * | 1997-12-24 | 1998-02-25 | Knoll Ag | Therapeutic agents |
-
1999
- 1999-06-24 GB GBGB9914744.9A patent/GB9914744D0/en not_active Ceased
-
2000
- 2000-06-16 SK SK1824-2001A patent/SK18242001A3/sk unknown
- 2000-06-16 BR BR0011880-0A patent/BR0011880A/pt not_active IP Right Cessation
- 2000-06-16 CA CA002375972A patent/CA2375972A1/en not_active Abandoned
- 2000-06-16 MX MXPA01012936A patent/MXPA01012936A/es unknown
- 2000-06-16 KR KR1020017016575A patent/KR20020015357A/ko not_active Ceased
- 2000-06-16 TR TR2001/03699T patent/TR200103699T2/xx unknown
- 2000-06-16 PL PL00352402A patent/PL352402A1/xx not_active Application Discontinuation
- 2000-06-16 CN CN00809372A patent/CN1358092A/zh active Pending
- 2000-06-16 AU AU55332/00A patent/AU5533200A/en not_active Abandoned
- 2000-06-16 HU HU0201878A patent/HUP0201878A3/hu unknown
- 2000-06-16 IL IL14707900A patent/IL147079A0/xx unknown
- 2000-06-16 CZ CZ20014613A patent/CZ20014613A3/cs unknown
- 2000-06-16 RU RU2002102076/14A patent/RU2229289C2/ru not_active IP Right Cessation
- 2000-06-16 JP JP2001505914A patent/JP2003503349A/ja active Pending
- 2000-06-16 WO PCT/EP2000/005542 patent/WO2001000205A1/en not_active Ceased
- 2000-06-16 EP EP00940379A patent/EP1187606A1/en not_active Withdrawn
- 2000-06-16 HK HK03100246.9A patent/HK1049278A1/zh unknown
-
2001
- 2001-12-04 BG BG106180A patent/BG106180A/xx unknown
- 2001-12-05 ZA ZA200109989A patent/ZA200109989B/xx unknown
- 2001-12-19 NO NO20016224A patent/NO20016224L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL352402A1 (en) | 2003-08-25 |
| MXPA01012936A (es) | 2004-04-21 |
| ZA200109989B (en) | 2003-02-26 |
| JP2003503349A (ja) | 2003-01-28 |
| CN1358092A (zh) | 2002-07-10 |
| AU5533200A (en) | 2001-01-31 |
| HK1049278A1 (zh) | 2003-05-09 |
| RU2229289C2 (ru) | 2004-05-27 |
| WO2001000205A1 (en) | 2001-01-04 |
| KR20020015357A (ko) | 2002-02-27 |
| NO20016224D0 (no) | 2001-12-19 |
| BR0011880A (pt) | 2002-03-19 |
| GB9914744D0 (en) | 1999-08-25 |
| TR200103699T2 (tr) | 2002-04-22 |
| IL147079A0 (en) | 2002-08-14 |
| HUP0201878A3 (en) | 2005-04-28 |
| SK18242001A3 (sk) | 2003-02-04 |
| HUP0201878A2 (hu) | 2003-08-28 |
| CZ20014613A3 (cs) | 2003-04-16 |
| CA2375972A1 (en) | 2001-01-04 |
| EP1187606A1 (en) | 2002-03-20 |
| BG106180A (en) | 2002-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20001651D0 (no) | Nedlasting av data | |
| DK1454907T3 (da) | Quninazolin og pyridopyrmidin-derivativer | |
| DK1112174T3 (da) | Isosorbidholdige polyestere og fremgangsmåder til fremstiling heraf | |
| DE69840172D1 (de) | Rna exportelement | |
| NO991151D0 (no) | Forbindelse og anvendelse derav | |
| DE69839157D1 (de) | Fullurene enthaltendes katherdersystem | |
| DE69805692D1 (de) | Uhrenarmband | |
| DE69928195D1 (de) | Komplettierung von Untrerdruck-Bohrlöchern | |
| PT1034144E (pt) | Vidro protegido | |
| DK199900820A (da) | Ørehænger | |
| NO20000057L (no) | Kjernerør | |
| DK1300129T3 (da) | Implantathætteglas | |
| PT869121E (pt) | Derivados de propanolamina hipolipidemicos | |
| DE69935609D1 (de) | Formulierungen enthaltend cefuroxim-axetil | |
| DE19882595T1 (de) | Schmuckstück | |
| DE59806331D1 (de) | Hohlschmuck | |
| NO20016224L (no) | Farmasöytisk blanding inneholdende sibutramin og orlistat | |
| DK0910369T3 (da) | Benzothiophener, formuleringer indeholdende samme og fremgangsmåder | |
| NO983802D0 (no) | Benzothiofener, formuleringer inneholdende samme og fremgangsmÕter | |
| DK1140952T3 (da) | Phosphororganiske forbindelser og anvendelse heraf | |
| FI102647B1 (fi) | Ohjelmoitava vahvistin | |
| DE19881428D2 (de) | Lustiges Gyros-Spielzeug | |
| KR960036347U (ko) | 팔찌 | |
| KR970053606U (ko) | 골프용 손목아대 | |
| UA3147S (uk) | Етикетка коньяку |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |